1. Predictive value of Obsessive–Compulsive Personality Disorder in antiobsessional pharmacological treatment
- Author
-
Stefano Erzegovesi, Paolo Cavedini, Paolo Ronchi, Laura Bellodi, Cavedini, P, Erzegovesi, S, Ronchi, P, and Bellodi, Laura
- Subjects
Adult ,Male ,Obsessive-Compulsive Disorder ,medicine.medical_specialty ,Clomipramine ,media_common.quotation_subject ,Fluvoxamine ,Antidepressive Agents, Tricyclic ,Pharmacological treatment ,Predictive Value of Tests ,medicine ,Humans ,Personality ,Pharmacology (medical) ,Psychiatry ,Biological Psychiatry ,media_common ,Psychiatric Status Rating Scales ,Pharmacology ,business.industry ,medicine.disease ,Personality disorders ,Obsessive–compulsive personality disorder ,Clinical trial ,Psychiatry and Mental health ,Neurology ,Predictive value of tests ,Antidepressive Agents, Second-Generation ,Female ,Neurology (clinical) ,business ,medicine.drug ,Clinical psychology - Abstract
Previous reports have stressed the implication of Personality Disorders as predictors of a poorer treatment outcome in Obsessive-Compulsive Disorder (OCD). The aim of this study was to see whether or not Obsessive-Compulsive Personality Disorder in Obsessive-Compulsive Disorder may be predictive for a poorer outcome to antiobsessive pro-serotonergic pharmacological treatment. For this purpose, 30 OCD patients were divided into two groups according to the presence or absence of Obsessive-Compulsive Personality Disorder. Ten-week standardized treatments with oral SRI drugs were given to look for different outcomes between the two groups in Obsessive-Compulsive symptom severity. At the end of the study we found that the presence of Obsessive-Compulsive Personality Disorder, along with the total number of Personality Disorders, did predict poorer response to pharmacological treatment in OCD. (C) 1997 Elsevier Science B.V. Z8 0 ZR 0 ZS 1 ZB 23
- Published
- 1997
- Full Text
- View/download PDF